Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-10

FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for ETRAVIRINE submitted by Patriot Pharmaceuticals, leading to changes to the drug's labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • etravirine (etravirine)

Snippet

SUPPL AP for ETRAVIRINE (ETRAVIRINE)